The analysis and follow-up study of Clopidogrel resistance of Coronary heart disease combine with diabetes patients
10.3969/j.issn.1006-5725.2017.03.031
- VernacularTitle:冠心病合并糖尿病患者氯吡格雷抵抗分析及随访
- Author:
Zhijun WANG
;
Zeyu WANG
;
Shuo WANG
;
Jianzhi ZHOU
;
Ning LIU
;
Zengli DIAO
;
Yuling HUANG
;
Tienan LIU
;
Haitao LI
- Keywords:
Coronary heart disease combine with diabetes;
Clopidogrel Resistance;
Analysis;
Follow-up study
- From:
The Journal of Practical Medicine
2017;33(3):447-450
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze Clopidogrel Resistance (CR) and influencing factors of coronary heart disease (CHD) with diabetes (DM) patients and evaluatc the relationship of CR and major adverse cardiovascular events (MACE) and readmission of CHD with DM patients.Methods 270 CHD patients were enrolled.Clinical conditions of CR were measured by adenosine diphosphate (ADP) induced maximum platelet aggregation rate (MPAR).After 1-year follow-up,MACE events and rehospitalization were recorded.Results CR of NDM and DM patients were 45 (33.1％) and 78 cases (58.2％) respectively,and the difference was significant (P ＜ 0.001).Factors of CR of CHD DM patients included heart rate,TG level,the number of severe coronary artery disease.MACE events of CS and CR patients were 35 (23.8％) and 47 patients (38.2％) respectively,and the difference was significant (P =0.010).The readmitted patients of CS and CR groups were 15 cases (10.2％) and 27 patients (22.0％) respectively,and the differcnce was significant (P =0.008).The MACE of CR and CS patients in DM group were 32 (41.0％) and 12 cases (21.4％) respectively,and thc difference was significant (P ＜ 0.05).The Readmitted cases of CR and CS patients in DM group were 19 (24.4％) and 5 (8.9％) respectively,and the diffcrcnce was significant (P ＜ 0.05).Conclusions CR of CHD DM patients increased significantly.The influencing factors of CR of CHDDM are including heart rate,TG level,the number of severe coronary artery disease.MACE events and rehospitalization rate were significantly increased in CHD patients with DM AR.Therefore,it should be further strengthened the anti-platelet therapy for CHD patients with DM.
